Detalhe da pesquisa
1.
Vaccine Effectiveness of JYNNEOS against Mpox Disease in the United States.
N Engl J Med
; 388(26): 2434-2443, 2023 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37199451
2.
Use of an Additional Updated 2023-2024 COVID-19 Vaccine Dose for Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024.
MMWR Morb Mortal Wkly Rep
; 73(16): 377-381, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38662708
3.
Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged ≥6 Months - United States, April 2023.
MMWR Morb Mortal Wkly Rep
; 72(24): 657-662, 2023 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37319020
4.
Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.
MMWR Morb Mortal Wkly Rep
; 72(41): 1115-1122, 2023 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37824423
5.
Use of Updated COVID-19 Vaccines 2023-2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2023.
MMWR Morb Mortal Wkly Rep
; 72(42): 1140-1146, 2023 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37856366
6.
Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox: A Multijurisdictional Case-Control Study - United States, August 19, 2022-March 31, 2023.
MMWR Morb Mortal Wkly Rep
; 72(20): 553-558, 2023 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37200229
7.
Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged ≥18 years - United States, July 2022.
MMWR Morb Mortal Wkly Rep
; 71(31): 988-992, 2022 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35925807
8.
Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines - United States, October 2022.
MMWR Morb Mortal Wkly Rep
; 71(45): 1436-1441, 2022 Nov 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36355612
9.
Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months-5 Years - United States, June 2022.
MMWR Morb Mortal Wkly Rep
; 71(26): 859-868, 2022 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35771731
10.
Demographic Characteristics of Persons Vaccinated During the First Month of the COVID-19 Vaccination Program - United States, December 14, 2020-January 14, 2021.
MMWR Morb Mortal Wkly Rep
; 70(5): 174-177, 2021 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33539333
11.
2015 Pandemic Influenza Readiness Assessment Among US Public Health Emergency Preparedness Awardees.
Am J Public Health
; 107(S2): S177-S179, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28892450
12.
Readiness to Vaccinate Critical Personnel During an Influenza Pandemic, United States, 2015.
Am J Public Health
; 107(10): 1643-1645, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28817330
13.
Key Elements for Conducting Vaccination Exercises for Pandemic Influenza Preparedness.
Am J Public Health
; 108(S3): S194-S195, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30192669
14.
A summary of the Advisory Committee for Immunization Practices (ACIP) use of a benefit-risk assessment framework during the first year of COVID-19 vaccine administration in the United States.
Vaccine
; 41(44): 6456-6467, 2023 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37527956
15.
Development of COVID-19 vaccine policy - United States, 2020-2023.
Vaccine
; 2023 Dec 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38158297
16.
Cost-effectiveness of increased influenza vaccination uptake against readmissions of major adverse cardiac events in the US.
PLoS One
; 14(4): e0213499, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31034485